Clinical Trial Update: Wellnara Post-marketing Surveillance in Japan

View source ↗

Summary

Bayer's Wellnara post-marketing surveillance study in Japan on osteoporosis (postmenopausal) has completed, collecting real-world safety and usage data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Wellnara

Snippet

Sponsor: Bayer | Conditions: Osteoporosis, Postmenopausal | Status: COMPLETED